Biogen Inc (BIIB)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	1,632,200	1,615,200	1,158,600	1,166,600	1,161,100	1,461,800	2,664,600	3,131,000	3,046,900	2,864,700	2,059,200	1,449,700	1,556,100	1,545,800	1,918,100	3,011,700	4,000,600	5,082,400	5,926,800	5,878,800
Revenue (ttm)	US$ in thousands	9,675,900	9,607,500	9,672,000	9,663,100	9,835,600	9,993,300	9,971,500	10,104,600	10,173,400	10,363,200	10,633,600	10,819,500	10,981,700	11,100,500	11,697,700	12,604,300	13,444,600	14,263,300	14,487,300	14,422,400
Net profit margin		16.87%	16.81%	11.98%	12.07%	11.81%	14.63%	26.72%	30.99%	29.95%	27.64%	19.37%	13.40%	14.17%	13.93%	16.40%	23.89%	29.76%	35.63%	40.91%	40.76%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,632,200K ÷ $9,675,900K
= 16.87%

Biogen Inc's net profit margin has displayed fluctuations over the quarters analyzed. The net profit margin decreased from 40.76% in March 2020 to 11.81% in December 2023 but showed a slight recovery to 16.87% by December 2024. Notably, the net profit margin reached its lowest point of 11.81% in December 2023, indicating a period of lower profitability for the company. However, there was a subsequent uptick in the net profit margin in the following quarters. It is important for stakeholders to closely monitor Biogen's net profit margin to assess the company's efficiency in generating profits from its revenue.